Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$66.79
-2.6%
$76.13
$66.63
▼
$101.40
$8.85B0.981.53 million shs1.51 million shs
ResMed Inc. stock logo
RMD
ResMed
$235.78
-0.5%
$233.55
$180.26
▼
$277.67
$33.16B0.771.31 million shs1.35 million shs
Veracyte, Inc. stock logo
VCYT
Veracyte
$25.09
+0.2%
$40.72
$21.91
▼
$60.91
$2.02B1.981.31 million shs2.79 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$390.36
-1.6%
$385.77
$223.83
▼
$438.27
$27.19B1.13801,052 shs604,863 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
-2.93%-5.18%-13.20%-21.02%-18.25%
ResMed Inc. stock logo
RMD
ResMed
-2.44%-0.76%-3.42%+2.39%-3.28%
Veracyte, Inc. stock logo
VCYT
Veracyte
-2.07%+1.66%-44.09%-40.82%-37.29%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-1.84%-3.55%+2.19%+12.53%+53.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$66.79
-2.6%
$76.13
$66.63
▼
$101.40
$8.85B0.981.53 million shs1.51 million shs
ResMed Inc. stock logo
RMD
ResMed
$235.78
-0.5%
$233.55
$180.26
▼
$277.67
$33.16B0.771.31 million shs1.35 million shs
Veracyte, Inc. stock logo
VCYT
Veracyte
$25.09
+0.2%
$40.72
$21.91
▼
$60.91
$2.02B1.981.31 million shs2.79 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$390.36
-1.6%
$385.77
$223.83
▼
$438.27
$27.19B1.13801,052 shs604,863 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
-2.93%-5.18%-13.20%-21.02%-18.25%
ResMed Inc. stock logo
RMD
ResMed
-2.44%-0.76%-3.42%+2.39%-3.28%
Veracyte, Inc. stock logo
VCYT
Veracyte
-2.07%+1.66%-44.09%-40.82%-37.29%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-1.84%-3.55%+2.19%+12.53%+53.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.63
Moderate Buy$96.0843.85% Upside
ResMed Inc. stock logo
RMD
ResMed
2.39
Hold$253.697.60% Upside
Veracyte, Inc. stock logo
VCYT
Veracyte
2.42
Hold$44.5077.38% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.93
Moderate Buy$424.678.79% Upside

Current Analyst Ratings Breakdown

Latest GMED, VCYT, WST, and RMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
Veracyte, Inc. stock logo
VCYT
Veracyte
UpgradeHold (C) ➝ Hold (C+)
11/11/2026
Veracyte, Inc. stock logo
VCYT
Veracyte
Lower Price TargetOverweight$55.00 ➝ $40.00
11/10/2026
Veracyte, Inc. stock logo
VCYT
Veracyte
Lower Price TargetOverweight$54.00 ➝ $30.00
11/9/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
DowngradeStrong-Buy ➝ Hold
11/9/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Lower Price TargetBuy$100.00 ➝ $90.00
11/9/2026
Veracyte, Inc. stock logo
VCYT
Veracyte
Lower Price TargetBuy$65.00 ➝ $35.00
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Reiterated RatingNeutral
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Lower Price TargetBuy$115.00 ➝ $105.00
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Boost Price TargetOverweight$99.00 ➝ $100.00
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Lower Price TargetBuy$117.00 ➝ $100.00
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
DowngradeOutperform ➝ Market Perform$94.00 ➝ $78.00
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$3.14B2.82$5.95 per share11.23$36.21 per share1.84
ResMed Inc. stock logo
RMD
ResMed
$5.65B5.87$12.57 per share18.76$42.28 per share5.58
Veracyte, Inc. stock logo
VCYT
Veracyte
$517.15M3.91$1.46 per share17.17$17.76 per share1.41
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$3.07B8.85$9.41 per share41.49$42.61 per share9.16
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$537.87M$4.0716.4112.561.0917.76%14.43%12.52%N/A
ResMed Inc. stock logo
RMD
ResMed
$1.52B$10.9821.4717.861.4727.79%26.42%19.43%1/28/2027 (Estimated)
Veracyte, Inc. stock logo
VCYT
Veracyte
$66.35M$1.5516.1921.63N/A21.80%8.99%8.34%N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$493.70M$8.9143.8138.202.4618.81%21.78%15.99%N/A

Latest GMED, VCYT, WST, and RMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.20$1.23+$0.03$1.04$792.39 million$763.72 million
11/4/2026Q3 2026
Veracyte, Inc. stock logo
VCYT
Veracyte
$0.41$0.51+$0.10$0.38$147.13 million$151.75 million
10/29/2026Q1 2027
ResMed Inc. stock logo
RMD
ResMed
$2.67$2.91+$0.24$2.92$1.39 billion$1.41 billion
10/29/2026Q3 2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.20$2.66+$0.46$3.02$827.12 million$874.50 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$2.641.12%+9.00%24.04%13 Years
Veracyte, Inc. stock logo
VCYT
Veracyte
N/AN/AN/AN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.040.27%+5.51%11.67%N/A

Latest GMED, VCYT, WST, and RMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/29/2026
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.661.1%11/12/202611/12/202612/17/2026
10/19/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.260.25%11/10/202611/11/202611/18/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
4.30
2.67
ResMed Inc. stock logo
RMD
ResMed
0.04
2.65
1.88
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A
5.56
5.25
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.07
2.82
2.10

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
ResMed Inc. stock logo
RMD
ResMed
54.98%
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.38%
ResMed Inc. stock logo
RMD
ResMed
0.58%
Veracyte, Inc. stock logo
VCYT
Veracyte
1.60%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
6,000132.47 million108.12 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
11,370140.66 million139.84 millionOptionable
Veracyte, Inc. stock logo
VCYT
Veracyte
75580.69 million79.40 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,80069.66 million69.24 millionOptionable

Recent News About These Companies

What is Zacks Research's Estimate for WST FY2026 Earnings?
West to Participate in Upcoming Investor Conference

New MarketBeat Followers Over Time

Media Sentiment Over Time

Globus Medical stock logo

Globus Medical NYSE:GMED

$66.79 -1.81 (-2.63%)
Closing price 03:59 PM Eastern
Extended Trading
$66.89 +0.09 (+0.14%)
As of 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

ResMed stock logo

ResMed NYSE:RMD

$235.78 -1.10 (-0.46%)
Closing price 03:59 PM Eastern
Extended Trading
$238.39 +2.61 (+1.11%)
As of 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Veracyte stock logo

Veracyte NASDAQ:VCYT

$25.09 +0.05 (+0.19%)
Closing price 03:59 PM Eastern
Extended Trading
$24.90 -0.19 (-0.75%)
As of 05:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$390.36 -6.33 (-1.60%)
Closing price 03:59 PM Eastern
Extended Trading
$390.48 +0.12 (+0.03%)
As of 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.